Komori
Other Disclosures4882Perseus Proteomics Inc.Pharmaceuticals

Notice Regarding On-Demand Streaming of the IR Briefing for Individual Investors

The recording of the IR briefing for individual investors held on 1 July 2026 has been made available as an archive for viewing at a later date.

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Archived IR Briefing for Individual Investors
Applicable field (uses covered by this announcement)

IR presentation for individual investors

Launch date6 July 2026 (the date of the notice regarding the archived recording; the distribution start time is not disclosed)
Relationship between the counterparty and the company
Perseus Proteomics Inc.4882
Relationship with the Company

The Company participated as a speaker at an IR seminar for individual investors organized by Wealth Advisor Co., Ltd. Capital and personnel relationships are not disclosed.

Counterpartyウエルスアドバイザー株式会社

Organizer of the IR seminar. Other information, including its location, representative, business activities, capital, and year of establishment, is not disclosed.

Location (as indicated in this announcement)

3rd Floor, A.i.Nihombashi EAST, 30-1 Nihombashihakozakicho, Chuo-ku, Tokyo

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredArchived IR Briefing for Individual Investors
Counterpartyウエルスアドバイザー株式会社
Counterparty overviewOrganizer of the IR seminar. Other information, including its location, representative, business activities, capital, and year of establishment, is not disclosed.
Relationship with the CompanyThe Company participated as a speaker at an IR seminar for individual investors organized by Wealth Advisor Co., Ltd. Capital and personnel relationships are not disclosed.
Launch date6 July 2026 (the date of the notice regarding the archived recording; the distribution start time is not disclosed)
Applicable areaIR presentation for individual investors
Location3rd Floor, A.i.Nihombashi EAST, 30-1 Nihombashihakozakicho, Chuo-ku, Tokyo
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To enable individual investors to watch the seminar and deepen their understanding of the Company.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding On-Demand Streaming of the IR Briefing for Individual Investors | Perseus Proteomics Inc. (4882) timely disclosure | Komori